p2PSA
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer (NCT05822726) | Ruijin Hospital | 2022-10-01 |
Track p2PSA automatically
Every clearance here is in the API, with alerts when new ones post.